Results 141 to 150 of about 145,947 (260)
Diurnal‐Only Foslevodopa/Foscarbidopa
Movement Disorders Clinical Practice, EarlyView.
Alexandra McGuckin +3 more
wiley +1 more source
Insomnia and Hypertension: Importance of Objective Phenotyping and Comorbidity with Sleep Apnea. [PDF]
Athanasiou N +2 more
europepmc +1 more source
Abstract Background Late effects of polio (LEoP) is a progressive condition leading to a lifelong disability that can affect mental health. There is limited knowledge of depressive symptoms and associated factors in people with LEoP. Objective To assess the occurrence of depressive symptoms in people with LEoP and explore the association with ...
Maria Nolvi +3 more
wiley +1 more source
Prevalence and determinants of insomnia in patients with chronic heart failure: a cross-sectional survey in Jiaxing, China. [PDF]
Jin H, Men X, Sun Y, Sheng Z, Wu L.
europepmc +1 more source
Medicinal plants used in ethnobotanical traditions to treat or prevent diseases have gained renewed interest for their largely untapped potential in drug discovery. In this study, we developed and tested novel methods to prioritise plant species based on their unexplored medicinal potential. By enabling researchers to target the most promising species,
Giovanni Zecca +3 more
wiley +1 more source
Effect of a supervised intermittent exercise program on insomnia in breast cancer patients undergoing chemotherapy. [PDF]
Drozd C +7 more
europepmc +1 more source
Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review
ABSTRACT The preclinical evidence for the safety of ashwagandha (Withania somnifera (L.) Dunal, AS) is reviewed, and its preparations (extracts) and constituents, from the general toxicity in animal models to in vitro and cell culture studies, which may elucidate mechanisms of action and explain clinical case reports.
Elizabeth M. Williamson, Thomas Brendler
wiley +1 more source
Adolescent Insomnia Disorder - Problematic Internet Use Nexus: A Convergent Developmental Trajectory - Bridging Neuroimaging Biomarkers, Molecular Susceptibility, and Environmental-Neurocognitive Cascades. [PDF]
Zeng Z +5 more
europepmc +1 more source
Schematic overview of the proposed neuromodulatory actions of linalool in Alzheimer's disease. Through multi‐target effects on oxidative stress, amyloid aggregation, GABAergic and glutamatergic signaling, linalool may restore excitatory/inhibitory balance.
Ilaria Piccialli +4 more
wiley +1 more source
The causal roles of metabolic traits in mediating the effects of insomnia on CVDs. CAD, coronary artery disease; HbA1c, hemoglobin A1c; HDL‐C, high‐density lipoprotein cholesterol; IR, insulin resistance; MI, myocardial infarction; TG, triglyceride; T2DM, type 2 diabetes.
Binhe Yu +12 more
wiley +1 more source

